Faculty Information - MIYAIRI Satoshi

（Last updated : 2022-02-18 19:43:37）

MIYAIRI Satoshi
Department School of Medicine(Tokyo Women's Medical University Hospital), School of Medicine Department of Surgery, Division of Cardiovascular Surgery

Position Assistant Professor

■ Published papers

1.	Original article	Recipient myeloperoxidase-producing cells regulate antibody-mediated acute versus chronic kidney allograft rejection. 2021/07/08
2.	Original article	Evaluation of the impact of conventional immunosuppressant on the establishment of murine transplantation tolerance - an experimental study. 2019/04
3.	Original article	Peritransplant VLA-4 blockade inhibits endogenous memory CD8 T cell infiltration into high-risk cardiac allografts and CTLA-4Ig resistant rejection. 2019/04
4.	Original article	In the absence of natural killer cell activation donor-specific antibody ediates chronic, but not acute, kidney allograft rejection. 2019/02
5.	Original article	iNKT cell activation plus T-cell transfer establishes complete chimerism in a murine sublethal bone marrow transplant model. 2018/02
6.	Original article	Donor bone marrow cells are essential for iNKT cell-mediated Foxp3+ Treg cell expansion in a murine model of transplantation tolerance. 2017/04
7.	Original article	Transitional B cells predominantly reconstituted after a desensitization therapy using rituximab before kidney transplantation. 2017/04
8.	Original article	Clonal deletion established via invariant NKT cell activation and costimulatory blockade requires in vivo expansion of regulatory T cells. 2016/02
9.	Other	The phenotype of repopulating B cell after rituximab therapy in kidney transplant patients. 2014/11
Display 5 items
Display all(9)

■ Academic conference presentation

1.	Fractalkine is crucial in ischemia reperfusion injury related to acute rejection in an allogeneic heart transplantation model. 2019/06/02
2.	VLA-4 blockade inhibits early endogenous memory CD8 T cell infiltration into higher risk cardiac allografts and donor-reactive T cell priming. 2018/06/03
3.	A novel method for iNKT cell-mediated ex vivo treg expansion applied to induce human transplant tolerance. 2017/05/01
4.	CD40/CD40 ligand signal controls cytotoxic ability of natural killer cells after invariant natural killer T cell stimulation. 2017/05/01
5.	Combination of veto cell transfer and NKT cell therapy helps establish complete hematopoietic chimerism in non-myeloablative BMT recipients. 2016/12/06
6.	In vitro stimulation of human/murine iNKT cells activates regulatory T cell through IL-2 production. 2016/12/06
7.	Islet allografts survive permanently by inducing hematopoietic chimerism by activating invariant natural killer T cells under CD40-CD154 signal blockade. 2016/12/06
8.	Contrasting effects of tacrolimus and everolimus on regulatory T cell activation and mixed hematopoietic chimerism induced by natural killer T cell stimulation. 2016/08/20
9.	Contrasting effects of tacrolimus and everolimus on regulatory T cell activation and mixed hematopoietic chimerism induced by natural Killer T cell stimulation. 2016/06/14
10.	iNKT cell ligands administered with bone marrow cells expand allo-specific regulatory T cells in vivo and establish Transplant Tolerance. 2016/06/14
11.	iNKT cell activation under co-stimulatory blockade establishes mixed chimerism through thymic regulatory T cell activation. 2016/06/12
12.	Induction of Acquired Cardiac Transplant Tolerance Through Natural Killer T-Cell Activation 2015/11/10
13.	Regulatory T cells expanded by activated iNKT cells facilitate migration of donor dendritic cells into the recipient thymus and subsequent establishment of clonal deletion. 2015/05/04
14.	The effect of rituximab therapy on regulatory B cell and prevention of chronic antibody mediated rejection in kidney transplantation recipients. 2015/05/04
15.	T cell transfer with iNKT cell activation facilitate engraftment of bone marrow cells without GvHD. 2015/05/03
16.	Donor specific tolerance can be induced by donor bone marrow transfer with activation of invariant naturel killer T cells. 2015/05/02
Display 5 items
Display all(16)

■ Education

2013/04～2017/03

〔Doctoral course〕, Tokyo Women's Medical University, Completed